Tenofovir Amibufenamide, a rising star in chronic hepatitis B...

adicionou um novo artigo Fitness

2026-01-13 08:34:05 - Traduzir

Tenofovir Amibufenamide, a rising star in chronic hepatitis B treatment: How to achieve significant therapeutic effects with low dosage?

2026-01-13 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...

0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior